The structural profiles are close, with Thermo Fisher Scientific carrying a narrow edge on valuation. Zimmer Biomet still has the edge on valuation, which keeps the comparison from looking entirely one-sided. The market setup broadly confirms the structural lead — Thermo Fisher Scientific holds the more constructive position. That puts structure and market broadly in agreement — Thermo Fisher Scientific's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.
The overall separation remains limited, with no one area creating a decisive distance.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
This level of similarity points to a meaningful structural match, though not a tight one.
The clearest structural overlap shows up in margin consistency and revenue stability.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
The setup splits cleanly: structure favours Thermo Fisher Scientific Inc., while the price setup favours Zimmer Biomet Holdings, Inc..
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where TMO and ZBH each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The peer-relative valuation gap is visible, with the stronger side also looking meaningfully cheaper.
Zimmer Biomet Holdings, Inc. still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.
The lead is visible, but the profile still looks more volatile than a fully settled winner.
Break down the TMO vs ZBH comparison across all dimensions with the full interactive tool.
Explore how TMO and ZBH each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.